CD4 MAb therapy diminishes sensitization to xenoantigen and abrogates hyperacute rejection of hamster cardiac grafts in rats.

Tomasz Sablinski(Icahn School of Medicine at Mount Sinai), Kupiec-Weglinski Jw, Milford El, G. Schmidbauer, Hancock Ww
PubMed
April 1, 1992
Cited by 3


Related Papers